Seroepidemiology of Norovirus‐Associated Travelers' Diarrhea

Norovirus vaccine development: next steps

(2012) Robert L Atmar et al.   Expert Review of Vaccines

Norovirus Infectivity in Humans and Persistence in Water

(2011) Scot R. Seitz et al.   APPLIED AND ENVIRONMENTAL MICROBIOLOGY

Serum Hemagglutination Inhibition Activity Correlates with Protection from Gastroenteritis in Persons Infected with Norwalk Virus

(2011) Rita Czakó et al.   Clinical and Vaccine Immunology

Serological Responses to Experimental Norwalk Virus Infection Measured Using a Quantitative Duplex Time-Resolved Fluorescence Immunoassay

(2011) Owen Kavanagh et al.   Clinical and Vaccine Immunology

Prevalence of norovirus GII-4 antibodies in Finnish children

(2011) K. Nurminen et al.   JOURNAL OF MEDICAL VIROLOGY

Norovirus Vaccine against Experimental Human Norwalk Virus Illness

(2011) Robert L. Atmar et al.   NEW ENGLAND JOURNAL OF MEDICINE

Characterization of Norovirus‐Associated Traveler's Diarrhea

(2010) N. Ajami et al.   CLINICAL INFECTIOUS DISEASES

Noroviruses as a Cause of Diarrhea in Travelers to Guatemala, India, and Mexico

(2010) H. L. Koo et al.   JOURNAL OF CLINICAL MICROBIOLOGY

Serological Correlate of Protection against Norovirus‐Induced Gastroenteritis

(2010) Amanda Reeck et al.   JOURNAL OF INFECTIOUS DISEASES

Norovirus Gastroenteritis

(2009) Roger I. Glass et al.   NEW ENGLAND JOURNAL OF MEDICINE

Mechanisms of GII.4 Norovirus Persistence in Human Populations

(2008) Lisa C Lindesmith et al.   PLOS MEDICINE